CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy

被引：0
|
作者：
Laura E. Jansen
Wendy A. Teft
Rhiannon V. Rose
Daniel J. Lizotte
Richard B. Kim
机构：
[1] Western University,Department of Medicine, Division of Clinical Pharmacology
[2] Western University,Department of Epidemiology and Biostatistics
[3] Western University,Department of Oncology
[4] LHSC-University Hospital,Department of Medicine
来源：
Breast Cancer Research and Treatment | 2018年 / 171卷
关键词：
Breast cancer; Tamoxifen; Endoxifen; Hot flash; Pharmacogenomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：701 / 708
页数：7
相关论文
共 50 条
  • [21] CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects
    Dezentje, V. O.
    Opdam, F. L.
    Gelderblom, H.
    den Hartigh, J.
    Van der Straaten, T.
    Vree, R.
    Maartense, E.
    Smorenburg, C. H.
    Putter, H.
    Dieudonne, A. S.
    Neven, P.
    Van de Velde, C. J. H.
    Nortier, J. W. R.
    Guchelaar, H. -J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (03) : 583 - 590
  • [22] CYP2D6 polymorphisms and endoxifen concentration in Chinese patients with breast cancer
    Xue, Cong
    Yang, Wei
    Hu, Anqi
    He, Caiyun
    Liao, Hai
    Chen, Meiting
    An, Xin
    Wang, Shusen
    Yuan, Zhongyu
    Xu, Fei
    Tang, Jun
    Li, Haifeng
    Li, Su
    Shao, Jianyong
    Shi, Yanxia
    BMC CANCER, 2025, 25 (01)
  • [23] Quantitative assessment of the effect of CYP2D6 genotype on tamoxifen metabolism: A model for CYP2D6 genotype-phenotype studies.
    Borges, S
    Desta, Z
    Jin, Y
    Li, L
    Skaar, TC
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P34 - P34
  • [24] Clinical outcomes in early breast cancer patients on adjuvant tamoxifen: Impact of CYP2D6 genotype and observed endoxifen concentrations
    Panuganty, Veera Durga Sravanthi
    Keller, Denise
    Teft, Wendy A.
    Lenehan, John Gordon
    Potvin, Kylea Raijann
    Younus, Jawaid
    Vandenberg, Theodorus Anthony
    Logan, Diane Mary
    Hahn, Karin
    Brackstone, Muriel
    Blanchette, Phillip Stanley
    Perera, Francisco
    Choi, Yun-Hee
    Kim, Richard Brian
    CANCER RESEARCH, 2020, 80 (04)
  • [25] Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohort
    Gryn, Steven E.
    Teft, Wendy A.
    Kim, Richard B.
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (07): : 367 - 369
  • [26] Endoxifen Levels and Its Association With CYP2D6 Genotype and Phenotype: Evaluation of a Southern Brazilian Population Under Tamoxifen Pharmacotherapy
    Antunes, Marina V.
    Linden, Rafael
    Santos, Tamyris V.
    Wallemacq, Pierre
    Haufroid, Vincent
    Classen, Jean-Francois
    Andreolla, Huander
    Costa, Nathalia
    Fontanive, Tiago O.
    Rosa, Daniela D.
    THERAPEUTIC DRUG MONITORING, 2012, 34 (04) : 422 - 431
  • [27] CYP2D6 Genotype and Tamoxifen: Considerations for Proper Nonprospective Studies
    Goetz, M. P.
    Ingle, J. N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (02) : 141 - 144
  • [28] Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio
    Lee, Clara Inkyung
    Low, Siew Kee
    Maldonado, Ricardo
    Fox, Peter
    Balakrishnar, Bavanthi
    Coulter, Sally
    de Bruijn, Peter
    Koolen, Stijn L. W.
    Gao, Bo
    Lynch, Jodi
    Zdenkowski, Nicholas
    Hui, Rina
    Liddle, Christopher
    Mathijssen, Ron H. J.
    Wilcken, Nicholas
    Wong, Mark
    Gurney, Howard
    BREAST, 2020, 54 : 229 - 234
  • [29] Erratum to: CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy
    Wendy A. Teft
    Inna Y. Gong
    Brian Dingle
    Kylea Potvin
    Jawaid Younus
    Theodore A. Vandenberg
    Muriel Brackstone
    Francisco E. Perera
    Yun-Hee Choi
    Guangyong Zou
    Robin M. Legan
    Rommel G. Tirona
    Richard B. Kim
    Breast Cancer Research and Treatment, 2013, 142 : 225 - 225
  • [30] The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels
    F. L. Opdam
    V. O. Dezentje
    J. den Hartigh
    A. S. Modak
    R. Vree
    E. Batman
    C. H. Smorenburg
    J. W. R. Nortier
    H. Gelderblom
    H.-J. Guchelaar
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 593 - 601
12345